Company Dashboard
Get the latest news, press releases, earnings, outlook, ratings, and dividends for any company.
Syndax Pharmaceuticals, Inc. ( NASDAQ : SNDX )
| Pre-Market | Intra-Day | After-Hours |
|---|---|---|
|
—
|
13.53
(
-0.42
/
-3.01%
)
|
—
|
| — | 14-Oct 16:00 | 13-Oct 19:00 |
| Previous Close | 13.95 | 52-Week Low | 12.99 |
| Open | 13.87 | 52-Week High | 25.59 |
| Day Low | 13.40 | 50-Day Average | 18.85 |
| Day High | 14.01 | 200-Day Average | 20.72 |
| Volume | 3.01 M | Market Cap | 1.2 B |
SNDX Earnings Calendar
Earnings reports, estimates, results and year-over-year growth for SNDX.
Showing
1 –
5
of
5
earnings records
from
2025-08-04
to
2026-08-04
| Symbol | Date | Time | Period | Metric | Actual | Estimate | Prior Year | Surprise | Growth | News |
|---|---|---|---|---|---|---|---|---|---|---|
| SNDX | 2026-08-04 | AMC | Q2 2026 | EPS | $-0.55 | $-0.44 | $-0.83 | Miss (-25.00%) | Up (+33.73%) | View |
| REV | $72.79 M | $79.32 M | $37.96 M | Miss (-8.23%) | Up (+91.75%) | |||||
| SNDX | 2026-04-30 | AMC | Q1 2026 | EPS | $-0.48 | $-0.58 | $-0.98 | Beat (+17.24%) | Up (+51.02%) | View |
| REV | $64.86 M | $70.44 M | $20.04 M | Miss (-7.92%) | Up (+223.65%) | |||||
| SNDX | 2026-02-26 | AMC | Q4 2025 | EPS | $-0.78 | $-0.58 | $-1.10 | Miss (-34.48%) | Up (+29.09%) | View |
| REV | $68.73 M | $63.97 M | $7.68 M | Beat (+7.44%) | Up (+794.92%) | |||||
| SNDX | 2025-11-03 | AMC | Q3 2025 | EPS | $-0.70 | $-0.72 | $-0.98 | Beat (+2.78%) | Up (+28.57%) | — |
| REV | $45.87 M | $47.98 M | $12.50 M | Miss (-4.40%) | Up (+266.96%) | |||||
| SNDX | 2025-08-04 | AMC | Q2 2025 | EPS | $-0.83 | $-1.00 | $-0.80 | Beat (+17.00%) | Down (-3.75%) | View |
| REV | $37.96 M | $26.78 M | $3.50 M | Beat (+41.75%) | Up (+984.57%) |
Sign up to see MORE news
Create your FREE CatalystPICR account to access MORE news and additional data.
Sign Up Free